Read on for some of the latest developments in cancer research.

• A new study led by researchers at the University of Michigan found that 10% of patients who had surgery that was expected to cure their cancer were still filling opioid prescriptions 1 year after their operation, with daily opioid doses similar to those in long-term opioid users. For more, see the Journal of Clinical Oncology.
• Investigators at Brigham and Women’s Hospital are leveraging artifical intelligence to develop a new method for detecting ovarian cancer at its earliest stage. They have identified a network of circulating microRNAs — small, non-coding pieces of genetic material — that are associated with risk of ovarian cancer and can be detected from a blood sample.  The findings have been published in eLIFE.
• The American Society Clinical Oncology (ASCO) in collaboration with Cancer Care Ontario (CCO) have recently published an update on the role of bone-modifying agents (BMAs) in metastatic breast cancer. You can read more about this update in the Journal of Clinical Oncology.